Ranzinger, J., A. Rustom, M. Abel, J. Leyh, L. Kihm, M. Witkowski, P. Scheurich, M. Zeier and V. Schwenger: Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses. In: PLoS ONE 6, 12, Seq. No.: e29537 (2011).
doi: 0.1371/journal.pone.0029537
Messerschmidt, S. K. E., A. Musyanovych, M. Altvater, P. Scheurich, K. Pfizenmaier, K. Landfester and R. E. Kontermann: Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized particles to tumor cells. In: Journal of Controlled Release 137, 1, 69-77 (2009).
localid: P-09-311
Ranzinger, J., A. Krippner-Heidenreich, T. Haraszti, E. Bock, J. Tepperink, J. P. Spatz and P. Scheurich: Nanoscale arrangement of apoptotic ligands reveals a demand for a minimal lateral distance for efficient death receptor activation. In: Nano Letters 9, 12, 4240-4245 (2009).
doi: 10.1021/nl902429b
Schlatter, R., K. Schmich, I. Avalos Vizcarra, P. Scheurich, T. Sauter, C. Borner, M. Ederer, I. Merfort and O. Sawodny: ON/OFF and Beyond - A Boolean Model of Apoptosis. In: PLoS Computational Biology 5, 12, Seq. No.: e1000595 (2009).
localid: OA 471606
url: http://dx.doi.org/10.1371/journal.pcbi.1000595
Eissing, T., H. Conzelmann, E. D. Gilles, F. Allgöwer, E. Bullinger and P. Scheurich: Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis. In: The Journal of Biological Chemistry 279, 36892-36897 (2004).
localid: 983 29/04
Vehmeyer, K., P. Scheurich, H. Eibl and C. Unger: HEXADECYLPHOSPHOCHOLINE-MEDIATED ENHANCEMENT OF T-CELL RESPONSES TO INTERLEUKIN-2. In: Cellular Immunology 137, 1, 232-238 (1991).
The Max Planck Society does not take any responsibility for the content of this export.